Association between the c.*229C > T polymorphism of the topoisomerase II beta binding protein 1 (TopBP1) gene and breast cancer

作者：Forma Ewa; Brzezianska Ewa; Krzeslak Anna; Chwatko Grazyna; Jozwiak Pawel; Szymczyk Agnieszka; Smolarz Beata; Romanowicz Makowska Hanna; Rozanski Waldemar; Brys Magdalena^*

来源：Molecular Biology Reports, 2013, 40(5): 3493-3502.

DOI：10.1007/s11033-012-2424-z

• Topoisomerase II beta binding protein 1
• Polymorphism
• Genetic variation
• Breast cancer

Topoisomerase II beta binding protein 1 (TopBP1) is involved in cell survival, DNA replication, DNA damage repair and cell cycle checkpoint control. The biological function of TopBP1 and its close relation with BRCA1 prompted us to investigate whether alterations in the TopBP1 gene can influence the risk of breast cancer. The aim of this study was to examine the association between five polymorphisms (rs185903567, rs116645643, rs115160714, rs116195487, and rs112843513) located in the 3'UTR region of the TopBP1 gene and breast cancer risk as well as allele-specific gene expression. Five hundred thirty-four breast cancer patients and 556 population controls were genotyped for these SNPs. Allele-specific TopBP1 mRNA and protein expressions were determined by using real time PCR and western blotting methods, respectively. Only one SNP (rs115160714) showed an association with breast cancer. Compared to homozygous common allele carriers, heterozygous and homozygous for the T variant had significantly increased risk of breast cancer (adjusted odds ratio = 3.81, 95 % confidence interval: 1.63-8.34, p = 0.001). Mean TopBP1 mRNA and protein expression were higher in the individuals with the CT or TT genotype. There was a significant association between the rs115160714 and tumor grade and stage. Most carriers of minor allele had a high grade (G3) tumors classified as T2-T4N1M0. Our study raises a possibility that a genetic variation of TopBP1 may be implicated in the etiology of breast cancer.

• 出版日期2013-5